Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1251

1.

Interferon Signaling is Diminished with Age and is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer.

Sceneay J, Goreczny GJ, Wilson K, Morrow S, DeCristo MJ, Ubellacker JM, Qin Y, Laszewski T, Stover DG, Barrera V, Hutchinson JN, Freedman RA, Mittendorf EA, McAllister SS.

Cancer Discov. 2019 Jun 19. pii: CD-18-1454. doi: 10.1158/2159-8290.CD-18-1454. [Epub ahead of print]

PMID:
31217296
2.

Transcription of PIK3CD in human brain and schizophrenia: Regulation by pro inflammatory cytokines.

Hood VL, Berger R, Freedman R, Law AJ.

Hum Mol Genet. 2019 Jun 18. pii: ddz144. doi: 10.1093/hmg/ddz144. [Epub ahead of print]

PMID:
31211828
3.

Breast cancer and aging: Standing on the shoulders of a giant.

Karuturi MS, Sedrak MS, Magnuson A, Freedman R, Jatoi A, Smith BD, Kimmick GG.

J Geriatr Oncol. 2019 Jun 11. pii: S1879-4068(19)30185-7. doi: 10.1016/j.jgo.2019.05.019. [Epub ahead of print] Review.

PMID:
31201096
4.

Arti Hurria, M.D.: A tribute to her shining legacy in the Alliance for Clinical Trials in Oncology.

Alliance Cancer in the Older Adult Committee, Adjei A, Buckner JC, Cathcart-Rake E, Chen H, Cohen HJ, Dao D, De Luca JE, Feliciano J, Freedman RA, Goldberg RM, Hopkins J, Hubbard J, Jatoi A, Karuturi M, Kemeny M, Kimmick GG, Klepin HD, Krok-Schoen JL, Lafky JM, Le-Rademacher JG, Li D, Lichtman SM, Maggiore R, Mandelblatt J, Morrison VA, Muss HB, Ojelabi MO, Sedrak MS, Subbiah N, Sun V, Tuttle S, VanderWalde N, Wildes T, Wong ML, Woyach J.

J Geriatr Oncol. 2019 Jun 11. pii: S1879-4068(19)30158-4. doi: 10.1016/j.jgo.2019.05.011. [Epub ahead of print] Review. No abstract available.

PMID:
31201095
5.

Developing a patient decision aid for women aged 70 and older with early stage, estrogen receptor positive, HER2 negative, breast cancer.

Schonberg MA, Freedman RA, Recht AR, Jacobson AR, Aliberti GM, Karamourtopoulos M, Nakhlis F, McCarthy EP, Pories SE, Sharma R, Dominici LS.

J Geriatr Oncol. 2019 May 23. pii: S1879-4068(19)30039-6. doi: 10.1016/j.jgo.2019.05.004. [Epub ahead of print]

PMID:
31130442
6.

Treatment Patterns Among De Novo Metastatic Cancer Patients Who Died Within 1 Month of Diagnosis.

Sineshaw HM, Jemal A, Ng K, Osarogiagbon RU, Robin Yabroff K, Ruddy KJ, Freedman RA.

JNCI Cancer Spectr. 2019 Jun;3(2):pkz021. doi: 10.1093/jncics/pkz021. Epub 2019 Apr 15.

7.

Impact of a Pre-Operative Exercise Intervention on Breast Cancer Proliferation and Gene Expression: Results from the Pre-Operative Health and Body (PreHAB) Study.

Ligibel JA, Dillon D, Giobbie-Hurder A, McTiernan A, Frank E, Cornwell M, Pun M, Campbell N, Dowling RJO, Chang MC, Tolaney S, Chagpar AB, Yung RL, Freedman RA, Dominici LS, Golshan M, Rhei E, Taneja K, Huang Y, Brown M, Winer EP, Jeselsohn R, Irwin ML.

Clin Cancer Res. 2019 Apr 24. doi: 10.1158/1078-0432.CCR-18-3143. [Epub ahead of print]

PMID:
31018921
8.

Who Are the Patients in Our Clinical Trials for Cancer?

Freedman RA, Ruddy KJ.

J Clin Oncol. 2019 Jun 20;37(18):1519-1523. doi: 10.1200/JCO.19.00382. Epub 2019 Apr 17. No abstract available.

PMID:
30995173
9.

Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715).

Dao D, Zemla T, Jatoi A, Freedman RA, Hurria A, Muss H, Cohen HJ, Shulman LN, Citron M, Budman D, McMurray R, Partridge A, Carey L, Sedrak MS, Lafky JM, Le-Rademacher JG.

Oncologist. 2019 Jun;24(6):e284-e291. doi: 10.1634/theoncologist.2018-0803. Epub 2019 Apr 11.

PMID:
30975921
10.

Quantitative Analyses of the Yeast Oxidative Protein Folding Pathway In Vitro and In Vivo.

Beal DM, Bastow EL, Staniforth GL, von der Haar T, Freedman RB, Tuite MF.

Antioxid Redox Signal. 2019 Apr 25. doi: 10.1089/ars.2018.7615. [Epub ahead of print]

PMID:
30880408
11.

Higher Gestational Choline Levels in Maternal Infection Are Protective for Infant Brain Development.

Freedman R, Hunter SK, Law AJ, Wagner BD, D'Alessandro A, Christians U, Noonan K, Wyrwa A, Hoffman MC.

J Pediatr. 2019 May;208:198-206.e2. doi: 10.1016/j.jpeds.2018.12.010. Epub 2019 Mar 14.

PMID:
30879727
12.

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.

Freedman RA, Gelman RS, Anders CK, Melisko ME, Parsons HA, Cropp AM, Silvestri K, Cotter CM, Componeschi KP, Marte JM, Connolly RM, Moy B, Van Poznak CH, Blackwell KL, Puhalla SL, Jankowitz RC, Smith KL, Ibrahim N, Moynihan TJ, O'Sullivan CC, Nangia J, Niravath P, Tung N, Pohlmann PR, Burns R, Rimawi MF, Krop IE, Wolff AC, Winer EP, Lin NU; Translational Breast Cancer Research Consortium.

J Clin Oncol. 2019 May 1;37(13):1081-1089. doi: 10.1200/JCO.18.01511. Epub 2019 Mar 12.

PMID:
30860945
13.

Impact of Subtype on Survival of Young Patients With Stage IV Breast Cancer.

Ogiya R, Sagara Y, Niikura N, Freedman RA.

Clin Breast Cancer. 2019 Jan 29. pii: S1526-8209(18)30604-9. doi: 10.1016/j.clbc.2019.01.005. [Epub ahead of print]

PMID:
30795886
14.

Examining Associations of Racial Residential Segregation With Patient Knowledge of Breast Cancer and Treatment Receipt.

Bonner SN, Clark C, Keating NL, Kouri EM, Freedman RA.

Clin Breast Cancer. 2018 Dec 8. pii: S1526-8209(18)30417-8. doi: 10.1016/j.clbc.2018.12.001. [Epub ahead of print]

PMID:
30685264
15.

Clinical Impact of Second Opinion Radiology Consultation for Patients With Breast Cancer.

Whorms DS, Giess CS, Golshan M, Freedman RA, Bunnell CA, Alper EC, Losk K, Khorasani R.

J Am Coll Radiol. 2019 Jun;16(6):814-823. doi: 10.1016/j.jacr.2018.10.010. Epub 2018 Dec 20.

PMID:
30579707
16.

Disseminating universal genetic testing to a diverse, indigent patient population at a county hospital gynecologic oncology clinic.

Bednar EM, Sun CC, Camacho B, Terrell J, Rieber AG, Ramondetta LM, Freedman RS, Lu KH.

Gynecol Oncol. 2019 Feb;152(2):328-333. doi: 10.1016/j.ygyno.2018.12.001. Epub 2018 Dec 8.

PMID:
30528888
17.

2018 in Review.

Freedman R, Lewis DA, Michels R, Pine DS, Rush AJ, Schultz SK, Tamminga CA, Glass O.

Am J Psychiatry. 2018 Dec 1;175(12):1163-1166. doi: 10.1176/appi.ajp.2018.18091065. No abstract available.

PMID:
30501415
18.

A Farewell.

Freedman R.

Am J Psychiatry. 2018 Dec 1;175(12):1155-1156. doi: 10.1176/appi.ajp.2018.18091108. No abstract available.

PMID:
30501411
19.

ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression.

Yeung TL, Tsai CC, Leung CS, Au Yeung CL, Thompson MS, Lu KH, Freedman RS, Birrer MJ, Wong KK, Mok SC.

Cancers (Basel). 2018 Nov 22;10(12). pii: E464. doi: 10.3390/cancers10120464.

20.

Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101.

Barginear M, Dueck AC, Allred JB, Bunnell C, Cohen HJ, Freedman RA, Hurria A, Kimmick G, Le-Rademacher JG, Lichtman S, Muss HB, Shulman LN, Copur MS, Biggs D, Ramaswamy B, Lafky JM, Jatoi A.

Oncologist. 2019 May;24(5):617-623. doi: 10.1634/theoncologist.2018-0298. Epub 2018 Nov 8.

PMID:
30409792

Supplemental Content

Loading ...
Support Center